Letters

Asensio & Company is under no obligation to disclose letter it writes to management. Please keep in mind that we often have a financial interest in these transactions and that these letters are written as part of an advocacy program in support of the thesis contained in our research.

No. Date Reports
17 June 10, 2016 Grant Thornton retains counsel in EROS’s “divided responsibility” audit matter.

16 June 9, 2016 asensio.com communicates with the U.S. Securities & Exchange Commission regarding EROS’s latest public statements.

15 June 7, 2016 asensio.com alerts the PCAOB to concerns over Grant Thornton’s audit of Eros International Plc.

14 June 7, 2016 Questions for Grant Thornton in connection with Eros’s divided responsibilty audit

13 October 23, 2002 Black Box Corporation

12 October 15, 2002 Black Box Corporation

11 September 12, 2002 Brocade Communications Systems, Inc.

10 September 10, 2002 Brocade Communications Systems, Inc.

9 June 4, 2002 Research Frontiers Incorporated

8 May 28, 2002 PolyMedica Corporation

7 May 15, 2002 PolyMedica Corporation

6 March 8, 2001 Winstar Communications, Inc.

5 March 8, 2001 Winstar Communications, Inc.

4 February 22, 2001 Winstar Communications, Inc.

3 February 16, 2001 Winstar Communications, Inc.

2 February 14, 2001 Winstar Communications, Inc.

1 September 30, 1998 Letter to FDA concerning Hemispherx violation of FDA regulations.